ACT201 clinical trials
How each study uses ACT201 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ACT201 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- ACT201 Injection
- 3
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
Who runs them
Industry 3 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test ACT201.
- Feb 2027Phase Ib Clinical Trial of ACT201 Injection in Participants With Treatment-Naïve Chronic Hepatitis BPhase 1 · Xiamen Amoytop Biotech Co., Ltd.
- Feb 2027ACT201 Injection in Participants With Chronic Hepatitis B (CHB) on Nucleos(t)Ide Analog Therapy - Phase IbPhase 1 · Xiamen Amoytop Biotech Co., Ltd.
- Mar 2027ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)Phase 1 · Xiamen Amoytop Biotech Co., Ltd.
Studies
Open first, then newest update. How each study uses ACT201 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Phase Ib Clinical Trial of ACT201 Injection in Participants With Treatment-Naïve Chronic Hepatitis BNot yet recruitingPhase 1Xiamen Amoytop Biotech Co., Ltd.NCT07946757Written as ACT201 Injection
- ACT201 Injection in Participants With Chronic Hepatitis B (CHB) on Nucleos(t)Ide Analog Therapy - Phase IbNot yet recruitingPhase 1Xiamen Amoytop Biotech Co., Ltd.NCT07929805Written as ACT201 Injection
- ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)RecruitingPhase 1Xiamen Amoytop Biotech Co., Ltd.NCT07741461Written as ACT201 Injection
What changed recently
From the registry's own updates since Oct 20, 2026.